NCT06618573View on ClinicalTrials.gov

Safety of Administering Isoniazid to SLE Patients to Prevent TB

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 15, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
TuberculosisSystemic Lupus Erythematosus
Interventions
DRUG

Isoniazid/Pyridoxine

Treatment group received isoniazid 300mg and pyridoxine 10mg/day

DRUG

Saccharum Lactis

Control group received placebo

Trial Locations (1)

40161

RECRUITING

Rumah Sakit Dr Hasan Sadikin, Universitas Padjadjaran, Bandung

All Listed Sponsors
lead

Universitas Padjadjaran

OTHER